Public Health Agency of Canada

The guidance identifies core personal and community-based public health measures to mitigate the transmission of coronavirus disease (COVID-19).

This tool will assist individuals, groups, or organizations, representing diverse groups based on gender, ethnicity/culture, and other socio-economic and demographic factors, in considering risks related to planning, organizing or operating gatherings/events during the coronavirus disease...

The FPT Special Advisory Committee (SAC) on COVID-19 provides advice to support a pan-Canadian coordinated approach to support governments' decisions in transition to living with COVID-19 in Canada.

The first version of the National laboratory testing indication guidance for COVID-19 document was developed at the beginning of the COVID-19 outbreak. The original guidance document was finalized and approved by the Special Advisory Committee on April 16, 2020. Since then, significant...

COVID-19 causes a respiratory type infection that is mild in most of the population but can be more severe in those who are older adults or those with chronic underlying conditions. Having a disability alone may not put you at higher risk for getting COVID-19 or having severe illness if you do...

The Public Health Agency of Canada (PHAC), in collaboration with Canadian public health experts has developed this guidance for federal/provincial/territorial (F/P/T) public health authorities (PHA) to support the management of cases and contacts of coronavirus disease 2019 (COVID-19) within...

This guidance updates and consolidates infection prevention and control guidance for managing COVID-19 in acute healthcare settings.

Research: Overview of the respiratory syncytial virus vaccine candidate pipeline in Canada. Published on Canada Communicable Disease Report (CCDR), volume 46-4, April 2, 2020.

The purpose of this document is to provide guidance to manufacturers of serological assays intended for the detection of antibodies to SARS-CoV-2, the virus that causes COVID-19 disease. The guidance outlines recommendations regarding the minimum testing that should be performed for SARS-CoV-2...

This document provides guidance specific to the COVID-19 pandemic for home care providers.

This biosafety advisory is being provided by the Public Health Agency of Canada (PHAC) to assist clinical, diagnostic, and research laboratories in implementing proper biosafety procedures to handle samples that may contain SARS-CoV-2.

The COVID-19 pandemic, along with related stressors and physical distancing measures, are affecting the mental health and well-being of many federal public servants. The risk landscape for workplace psychological health and safety is also changing as a result. There are at least 13 psychosocial...

Scientists and senior doctors have backed claims by France’s health minister that people showing symptoms of covid-19 should use paracetamol (acetaminophen) rather than ibuprofen, a drug they said might exacerbate the condition.

The Government of Canada released national-level modelling on the COVID-19 epidemic in Canada. The modelling attempts to show how the epidemic might unfold over the coming months based on our knowledge of how the virus behaves and the potential impact of public health measures.

The Government of Canada supports First Nations and Inuit communities in preparing for, monitoring and responding to COVID-19 and raises awareness on infection prevention and control.

The Physical Activity, Sedentary Behaviour and Sleep (PASS) Indicators provides important surveillance information on physical activity, sedentary and sleep behaviours in Canadians, as well as factors that influence them. The PASS Indicators are grouped by movement behaviour (physical activity,...

The Congenital Anomalies data tool was developed by the Canadian Congenital Anomalies Surveillance System (CCASS) to present prevalence rates, temporal trends and certain factors associated with congenital anomalies in Canada. This resource is a collaborative effort between the Public Health...

The Positive Mental Health Surveillance Indicator Framework (PMHSIF) provides information on positive mental health outcomes and its associated risk and protective factors.

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice(the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada. The journal publishes articles on disease...

Notifiable Diseases Online presents information based on data from the Canadian Notifiable Disease Surveillance System (CNDSS). Nationally notifiable diseases are infectious diseases that have been identified by the federal government and provinces and territories as priorities for monitoring and...